EFFICACY AND SAFETY OF SAXAGLIPTIN IN COMBINATION WITH INSULIN IN PATIENTS WITH LONG-STANDING TYPE 2 DIABETES

被引：0
|
作者：
Iqbal, Nayyar [4 ]
Minervini, Gianmaria [1 ]
Charbonnel, Bernard [2 ]
Barnett, Anthony [3 ]
Monyak, John [1 ]
机构：
[1] AstraZeneca, Wilmington, DE USA
[2] Ctr Hosp Univ Nantes, Nantes, France
[3] Univ Birmingham, Birmingham B15 2TT, W Midlands, England
[4] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
INTERNAL MEDICINE JOURNAL | 2013年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [11] Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment
    Perl, Shira
    Cook, William
    Wei, Cheryl
    Iqbal, Nayyar
    Hirshberg, Boaz
    DIABETES THERAPY, 2016, 7 (03) : 527 - 535
  • [12] Efficacy and Safety of Saxagliptin in Patients with Type 2 Diabetes: Outcomes by Race and Ethnicity
    Barrett, Yu Chen
    Minervini, Gianmaria
    Chen, Hungta
    Ghannam, Ameen
    DIABETES, 2015, 64 : A323 - A323
  • [13] Efficacy and safety of saxagliptin and metformin as initial combination therapy in patients with type 2 diabetes: a meta-analysis
    Tan, Xue-Ying
    Lu, Yang
    Xuan, Li-Ping
    Huang, Yong-Min
    Hu, Jing-Bo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 18816 - 18823
  • [14] A Pooled Analysis of the Efficacy and Safety of Saxagliptin as Monotherapy in Patients with Type 2 Diabetes
    Hirshberg, Boaz
    Bryzinski, Brian
    Xu, John
    Iqbal, Nayyar
    JOURNAL OF DIABETES & METABOLISM, 2015, 6 (04)
  • [15] Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment
    Shira Perl
    William Cook
    Cheryl Wei
    Nayyar Iqbal
    Boaz Hirshberg
    Diabetes Therapy, 2016, 7 : 527 - 535
  • [16] Efficacy and Safety of Saxagliptin as Monotherapy in Patients with Type 2 Diabetes: A Pooled Analysis
    Hirshberg, Boaz
    Bryzinski, Brian
    Xu, John
    Monyak, John
    Iqbal, Nayyar
    DIABETES, 2014, 63 : A610 - A610
  • [17] Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus
    Inagaki, Nobuya
    Harashima, Shin-ichi
    Kaku, Kohei
    Kondo, Kazuoki
    Maruyama, Nobuko
    Otsuka, Makiko
    Kawaguchi, Yutaka
    Iijima, Hiroaki
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 812 - 820
  • [18] Long-Term Efficacy and Safety of Saxagliptin in a Triple-Therapy Regimen With Insulin and Metformin for Type 2 Diabetes
    Charbonnel, Bernard
    Barnett, Anthony H.
    Monyak, John
    Minervini, Gianmaria
    Iqbal, Nayyar
    DIABETES, 2012, 61 : A292 - A292
  • [19] Efficacy and safety of saxagliptin for the treatment of type 2 diabetes mellitus
    Orime, Kazuki
    Terauchi, Yasuo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) : 2101 - 2114
  • [20] Efficacy and Safety of Saxagliptin plus Metformin as Initial Therapy in Patients with Type 2 Diabetes
    Dou, Jingtao
    Ma, Jianhua
    Liu, Jun
    Wang, Changjiang
    Johnsson, Eva
    Yao, Yolanda
    Zhao, June
    Pan, Changyu
    DIABETES, 2017, 66 : A327 - A327
12345